Search

Your search keyword '"Kioko, Urbanus"' showing total 24 results
Start Over Author "Kioko, Urbanus"
24 results on '"Kioko, Urbanus"'

10. Making voluntary medical male circumcision services sustainable: Findings from Kenya’s pilot models, baseline and year 1

Author

Davis, Stephanie M., primary, Owuor, Nandi, additional, Odoyo-June, Elijah, additional, Wambua, Jonesmus, additional, Omanga, Eunice, additional, Lukobo, Mainza, additional, Laube, Catharine, additional, Mwandi, Zebedee, additional, Suraratdecha, Chutima, additional, Kioko, Urbanus M., additional, Rotich, Wesley, additional, Kataka, Jacquin, additional, Ng’eno, Caroline, additional, Mohan, Diwakar, additional, Toledo, Carlos, additional, Aoko, Appolonia, additional, Anyango, John, additional, Oneya, Daniel, additional, Orenjuro, Kennedy, additional, Mgamb, Elizabeth, additional, Serrem, Kennedy, additional, and Juma, Ambrose, additional

Published
2021
Full Text
View/download PDF

15. Knowledge and Adherence to the National Guidelines for Malaria Diagnosis in Pregnancy among Health-Care Providers and Drug-Outlet Dispensers in Rural Western Kenya

Author

Riley, Christina, primary, Dellicour, Stephanie, additional, Ouma, Peter, additional, Kioko, Urbanus, additional, Omar, Ahmeddin, additional, Kariuki, Simon, additional, Ng'ang'a, Zipporah, additional, Desai, Meghna, additional, Buff, Ann M., additional, and Gutman, Julie R., additional

Published
2018
Full Text
View/download PDF

16. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013

Author

Kioko, Urbanus, Riley, Christina, Dellicour, Stephanie, Were, Vincent, Ouma, Peter, Gutman, Julie, Kariuki, Simon, Omar, Ahmeddin, Desai, Meghna, and Buff, Ann M

Subjects
parasitic diseases, qv_256, wc_765, f0e481db, health care economics and organizations, wc_750
Abstract

BACKGROUND\ud Although anti-malarial medicines are free in Kenyan public health facilities, patients often seek treatment from private sector retail drug outlets. In mid-2010, the Affordable Medicines Facility-malaria (AMFm) was introduced to make quality-assured artemisinin-based combination therapy (ACT) accessible and affordable in private and public sectors.\ud \ud METHODS\ud Private sector retail drug outlets stocking anti-malarial medications within a surveillance area of approximately 220,000 people in a malaria perennial high-transmission area in rural western Kenya were identified via a census in September 2013. A cross-sectional study was conducted in September-October 2013 to determine availability and price of anti-malarial medicines and malaria rapid diagnostic tests (RDTs) in drug outlets. A standardized questionnaire was administered to collect drug outlet and personnel characteristics and availability and price of anti-malarials and RDTs.\ud \ud RESULTS\ud Of 181 drug outlets identified, 179 (99 %) participated in the survey. Thirteen percent were registered pharmacies, 25 % informal drug shops, 46 % general shops, 13 % homesteads and 2 % other. One hundred sixty-five (92 %) had at least one ACT type: 162 (91 %) had recommended first-line artemether-lumefantrine (AL), 22 (12 %) had recommended second-line dihydroartemisinin-piperaquine (DHA-PPQ), 85 (48 %) had sulfadoxine-pyrimethamine (SP), 60 (34 %) had any quinine (QN) formulation, and 14 (8 %) had amodiaquine (AQ) monotherapy. The mean price (range) of an adult treatment course for AL was $1.01 ($0.35-4.71); DHA-PPQ was $4.39 ($0.71-7.06); QN tablets were $2.24 ($0.12-4.71); SP was $0.62 ($0.24-2.35); AQ monotherapy was $0.42 ($0.24-1.06). The mean AL price with or without the AMFm logo did not differ significantly ($1.01 and 1.07, respectively; p = 0.45). Only 17 (10 %) drug outlets had RDTs; 149 (84 %) never stocked RDTs. The mean RDT price was $0.92 ($0.24-2.35).\ud \ud CONCLUSIONS\ud Most outlets never stocked RDTs; therefore, testing prior to treatment was unlikely for customers seeking treatment in the private retail sector. The recommended first-line treatment, AL, was widely available. Although SP and AQ monotherapy are not recommended for treatment, both were less expensive than AL, which might have caused preferential use by customers. Interventions that create community demand for malaria diagnostic testing prior to treatment and that increase RDT availability should be encouraged.

Published
2016

17. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study

Author

Masyuko, Sarah, primary, Mukui, Irene, additional, Njathi, Olivia, additional, Kimani, Maureen, additional, Oluoch, Patricia, additional, Wamicwe, Joyce, additional, Mutegi, Jane, additional, Njogo, Susan, additional, Anyona, Micah, additional, Muchiri, Phillip, additional, Maikweki, Lucy, additional, Musyoki, Helgar, additional, Bahati, Prince, additional, Kyongo, Jordan, additional, Marwa, Tom, additional, Irungu, Elizabeth, additional, Kiragu, Michael, additional, Kioko, Urbanus, additional, Ogando, Justus, additional, Were, Dan, additional, Bartilol, Kigen, additional, Sirengo, Martin, additional, Mugo, Nelly, additional, Baeten, Jared M., additional, Cherutich, Peter, additional, and PrEP technical working group, on behalf of the, additional

Published
2018
Full Text
View/download PDF

18. Accessibility of long-term family planning methods: a comparison study between Output Based Approach (OBA) clients verses non-OBA clients in the voucher supported facilities in Kenya

Author

Oyugi, Boniface, primary, Kioko, Urbanus, additional, Kaboro, Stephen Mbugua, additional, Gikonyo, Shadrack, additional, Okumu, Clarice, additional, Ogola-Munene, Sarah, additional, Kalsi, Shaminder, additional, Thiani, Simon, additional, Korir, Julius, additional, Odundo, Paul, additional, Baltazaar, Billy, additional, Ranji, Moses, additional, Muraguri, Nicholas, additional, and Nzioka, Charles, additional

Published
2017
Full Text
View/download PDF

21. Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya

Author

Riley, Christina, primary, Dellicour, Stephanie, additional, Ouma, Peter, additional, Kioko, Urbanus, additional, ter Kuile, Feiko O., additional, Omar, Ahmeddin, additional, Kariuki, Simon, additional, Buff, Ann M., additional, Desai, Meghna, additional, and Gutman, Julie, additional

Published
2016
Full Text
View/download PDF

22. The impact of fiscal decentralisation reform on hospital efficiency : the case of Kenya

Author

Kioko, Urbanus M and McIntyre, Di

Subjects
Public Health
Abstract

Bibliography: leaves 105-112., Many developing countries have or are in the process of implementing decentralisation of financial management systems. The reform can take various forms: self-financing or cost recovery through user charges and co-financing or expansion of local revenue through taxation. This study examines the impact of decentralisation of fiscal financial management of cost sharing revenue on hospital efficiency. Potentially, decentralisation of financial management of cost sharing is expected to improve coverage and accessibility of health services, quality of services and efficiency in the delivery of health care. The main aim of this study was to review the impact of fiscal decentralisation or the cost sharing reform on the efficiency of Kenya's health care delivery and to identify factors that need to be addressed in order to enhance the success of the reform policy.

Published
2000

24. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.

Author

Kioko U, Riley C, Dellicour S, Were V, Ouma P, Gutman J, Kariuki S, Omar A, Desai M, and Buff AM

Subjects
Cross-Sectional Studies, Humans, Kenya, Private Sector, Rural Population, Surveys and Questionnaires, Time Factors, Antimalarials economics, Antimalarials supply & distribution, Diagnostic Tests, Routine economics, Malaria diagnosis, Malaria drug therapy, Reagent Kits, Diagnostic economics, Reagent Kits, Diagnostic supply & distribution
Abstract

Background: Although anti-malarial medicines are free in Kenyan public health facilities, patients often seek treatment from private sector retail drug outlets. In mid-2010, the Affordable Medicines Facility-malaria (AMFm) was introduced to make quality-assured artemisinin-based combination therapy (ACT) accessible and affordable in private and public sectors., Methods: Private sector retail drug outlets stocking anti-malarial medications within a surveillance area of approximately 220,000 people in a malaria perennial high-transmission area in rural western Kenya were identified via a census in September 2013. A cross-sectional study was conducted in September-October 2013 to determine availability and price of anti-malarial medicines and malaria rapid diagnostic tests (RDTs) in drug outlets. A standardized questionnaire was administered to collect drug outlet and personnel characteristics and availability and price of anti-malarials and RDTs., Results: Of 181 drug outlets identified, 179 (99 %) participated in the survey. Thirteen percent were registered pharmacies, 25 % informal drug shops, 46 % general shops, 13 % homesteads and 2 % other. One hundred sixty-five (92 %) had at least one ACT type: 162 (91 %) had recommended first-line artemether-lumefantrine (AL), 22 (12 %) had recommended second-line dihydroartemisinin-piperaquine (DHA-PPQ), 85 (48 %) had sulfadoxine-pyrimethamine (SP), 60 (34 %) had any quinine (QN) formulation, and 14 (8 %) had amodiaquine (AQ) monotherapy. The mean price (range) of an adult treatment course for AL was $1.01 ($0.35-4.71); DHA-PPQ was $4.39 ($0.71-7.06); QN tablets were $2.24 ($0.12-4.71); SP was $0.62 ($0.24-2.35); AQ monotherapy was $0.42 ($0.24-1.06). The mean AL price with or without the AMFm logo did not differ significantly ($1.01 and 1.07, respectively; p = 0.45). Only 17 (10 %) drug outlets had RDTs; 149 (84 %) never stocked RDTs. The mean RDT price was $0.92 ($0.24-2.35)., Conclusions: Most outlets never stocked RDTs; therefore, testing prior to treatment was unlikely for customers seeking treatment in the private retail sector. The recommended first-line treatment, AL, was widely available. Although SP and AQ monotherapy are not recommended for treatment, both were less expensive than AL, which might have caused preferential use by customers. Interventions that create community demand for malaria diagnostic testing prior to treatment and that increase RDT availability should be encouraged.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results